Related Experiment Videos
Molecular pathogenesis of neonatal hypothyroidism
H Krude1, H Biebermann, D Schnabel
1Department of Pediatrics, Charité University Hospital, Humboldt University, Berlin, Germany.
Hormone Research
|July 15, 2000
Summary
Genetic mutations in thyroid peroxidase, thyroglobulin, and sodium iodide transporter genes cause congenital hypothyroidism (CH). Recent studies reveal inheritable defects in thyroid development, impacting genetic counseling for CH patients.
Area of Science:
- Endocrinology
- Genetics
- Pediatrics
Background:
- Congenital hypothyroidism (CH) is often linked to mutations in thyroid peroxidase, thyroglobulin, NIS, and pendrin genes.
- Thyroid dysgenesis was previously considered sporadic, but inheritable defects in thyroid development are now recognized.
- Mutations in the thyroid-stimulating hormone receptor and Pax-8 genes are identified in CH with thyroid hypoplasia and dysgenesis, respectively.
Purpose of the Study:
- To review the genetic basis of congenital hypothyroidism.
- To highlight recent findings on inheritable defects in thyroid development.
- To emphasize the role of molecular genetic studies in CH management.
Main Methods:
- Review of molecular genetic studies in congenital hypothyroidism.
- Analysis of mutations in genes related to thyroid hormone synthesis and thyroid development.
- Correlation of genetic findings with clinical phenotypes in CH patients.
Main Results:
- Autosomal recessive inheritance identified for mutations in thyroid peroxidase, thyroglobulin, NIS, and pendrin genes.
- Autosomal recessive mutations in the thyroid-stimulating hormone receptor gene found in CH with thyroid hypoplasia.
- Autosomal dominant mutations in the Pax-8 gene identified in patients with thyroid dysgenesis.
- Mutations in the beta-thyrotropin gene provide insights into central CH pathogenesis.
Conclusions:
- Molecular genetic studies are crucial for understanding CH pathogenesis.
- Identifying genetic causes aids in genetic counseling for CH patients and families.
- Genetic insights may explain the variable outcomes observed in some CH cases detected by newborn screening.